Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease

This publication has 40 references indexed in Scilit:

• Activation of nuclear factor kappa B in inflammatory bowel disease
  Gut, 1998
• IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach.
  Journal of Clinical Investigation, 1998
• THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
  Annual Review of Immunology, 1996
• Interleukin (IL)-10 Inhibits Nuclear Factor кB (NFкB) Activation in Human Monocytes
  Journal of Biological Chemistry, 1995
• The MOS 36-Item Short-Form Health Survey (SF-36)
  Medical Care, 1993
• The MOS 36-ltem Short-Form Health Survey (SF-36)
  Medical Care, 1992
• Tumor necrosis factor-?, interleukin-1?, and interleukin-6 expression in inflammatory bowel disease
  Digestive Diseases and Sciences, 1992
• Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine
  Clinical and Experimental Immunology, 1990
• Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease.
  Gut, 1989
• SOME RAPID APPROXIMATE STATISTICAL PROCEDURES
  Annals of the New York Academy of Sciences, 1950